Liposomal iron

Liposomal encapsulation technology enhances the bioavailability of iron by encasing it within phospholipid vesicles, facilitating direct transport into the bloodstream and improving cellular uptake. This method increases absorption rates and reduces gastrointestinal discomfort, such as nausea and constipation, often associated with conventional iron supplements.

Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients: This study (3) found that oral liposomal iron was non-inferior to injectable iron sucrose, suggesting it is an effective alternative to intravenous iron therapy.

Treatment of Iron Deficiency Anemia with Liposomal Iron in Inflammatory Bowel Disease Patients: Liposomal iron significantly improved haemoglobin and ferritin levels with minimal side effects in IBD patients. (2)

Efficacy and Safety of Oral Supplementation with Liposomal Iron in Patients with Non-Dialysis-Dependent Chronic Kidney Disease: This study demonstrated that liposomal iron effectively increased patient transferrin saturation, indicating improved iron status. (1)

Safety and Efficacy of Oral Liposomal Iron Supplemented in Cancer Patients Receiving Chemotherapy and Epoetin Alfa: The research indicated that liposomal iron supplementation increased haemoglobin levels without significant adverse effects, supporting its use in oncology settings. (4)

1 week of liposomal iron has been shown to be equivalent to an intravenous infusion of iron.

Take one capsule per day with or without food